Alexandria Venture Investments

Venture Capital Active United States
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$215.0M
total disclosed, rounds participated
Stages
—

Portfolio · 1

Immunai
Peripheral Tissue Analysis
1 round $215.0M committed Latest: 2021-10

Investment activity

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Alexandria Venture Investments' primary investment focus?
Alexandria Venture Investments focuses on the Health Tech & Life Sciences sector, with its sole recorded portfolio company, Immunai, operating in this area.
Can you name a notable portfolio company for Alexandria Venture Investments?
Immunai is a notable portfolio company for Alexandria Venture Investments. It operates in the Health Tech & Life Sciences sector.
When did Alexandria Venture Investments make its most recent recorded investment?
Alexandria Venture Investments made its most recent recorded investment in October 2021.
What stage of funding does Alexandria Venture Investments typically participate in?
Alexandria Venture Investments has participated in B Round funding stages, as seen with its investment in Immunai.
What was the funding amount for Immunai's B Round, in which Alexandria Venture Investments participated?
Immunai raised $295M in its B Round, which included participation from Alexandria Venture Investments.